{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AARD"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":7.13,"timestamp":1745262150841,"preClose":7,"halted":0,"volume":6534,"delay":0,"floatShares":5900000,"shares":21384400,"eps":-0.648,"marketStatus":"Trading","change":0.13,"latestTime":"04-21 15:03:54 EDT","open":6.86,"high":7.15,"low":6.75,"amount":45645.785658,"amplitude":0.057143,"askPrice":7.12,"askSize":209,"bidPrice":6.96,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-0.648,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745265600000},"marketStatusCode":2,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":7,"postHourTrading":{"tag":"盘后","latestPrice":7,"preClose":7,"latestTime":"17:16 EDT","volume":21,"amount":145.2,"timestamp":1744924608596},"volumeRatio":0.164747},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","floatShares":5900000,"roa":"-32.35%","roe":"-50.70%","lyrEps":-0.74,"volumeRatio":0.164747,"shares":21384400,"dividePrice":0,"high":7.15,"amplitude":0.057143,"preClose":7,"low":6.75,"week52Low":4.88,"pbRate":"-2.79","week52High":19.58,"institutionHeld":0,"latestPrice":7.13,"committee":-0.825328,"eps":-0.648,"divideRate":0,"volume":6534,"delay":0,"ttmEps":-0.648,"open":6.86,"prevYearClose":16,"prevWeekClose":7,"prevMonthClose":7.51,"prevQuarterClose":7.51,"fiveDayClose":7.14,"twentyDayClose":9.91,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AARD\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AARD\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524145519","title":"Aardvark Therapeutics Price Target Maintained With a $50.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2524145519","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524145519?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:16","pubTimestamp":1743520560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 11:16 ET (15:16 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2524897401","title":"Aardvark Therapeutics FY24 EPS (5.15) Down From ($1.82) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2524897401","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524897401?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:15","pubTimestamp":1743452149,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics FY24 EPS (5.15) Down From ($1.82) YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44571255/aardvark-therapeutics-fy24-eps-5-15-down-from-1-82-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2524097441","title":"Press Release: Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2524097441","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524097441?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:10","pubTimestamp":1743451800,"startTime":"0","endTime":"0","summary":"-- Lead candidate ARD-101 demonstrated clinical activity and was generally. well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome ,with meaningful reductions in hyperphagia (up to a 16-point HQ-CT. reduction, with an average reduction of approximately 8 points among. subjects that followed trial protocol) observed during the 28-day dosing. -- DEXA scans analysis from the PWS Phase 2 trial data measuring body. composition indicated a trend toward decreased body fat (approximately. -- Aardvark bolstered its cash runway through the successful completion of. SAN DIEGO, March 31, 2025  -- Aardvark Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today reported financial results for the full year ended December 31, 2024, and provided business highlights.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PWS","IPO","AARD"],"gpt_icon":0},{"id":"2522658517","title":"BUZZ-Ultragenyx Pharma up after JPMorgan PT raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2522658517","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522658517?lang=en_us&edition=fundamental","pubTime":"2025-03-27 23:34","pubTimestamp":1743089680,"startTime":"0","endTime":"0","summary":"BUZZ-Ultragenyx Pharma up after JPMorgan PT raise** Shares of drugmaker Ultragenyx Pharmaceutical RARE.O rise 2% to $38.75** JPMorgan raises RARE's target price to $117 from $104** Believes RARE is uniquely positioned in the long term with a broad and diverse pipeline of orphan disease assets and a highly regarded management team - JPMorgan ** 19 of 20 brokerages rate the stock \"buy\" or higher, one \"hold\"; their median PT is $87, according to data compiled by LSEG** Up to last close, stock had fallen ~10% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL3N3QA1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE","BK4139","AARD"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AARD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"AARD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AARD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AARD","date":"2025-04-17","current":-7.977371,"percent":0.928571,"low":-51.17654,"twenty":-38.300819,"median":-28.45119,"eighty":-8.603741,"high":-7.397773,"avg":-26.26435,"sd":12.449247,"marketCap":164238114},"quantilePoints":[{"date":"2025-02-21","current":-51.17654,"twenty":-46.993414,"median":-42.216938,"eighty":-39.920668,"marketCap":368880503},{"date":"2025-02-28","current":-39.75453,"twenty":-42.139802,"median":-40.229211,"eighty":-39.232381,"marketCap":286550651},{"date":"2025-03-07","current":-28.243517,"twenty":-40.603022,"median":-39.176012,"eighty":-36.900511,"marketCap":203579269},{"date":"2025-03-14","current":-31.091602,"twenty":-40.336014,"median":-37.766803,"eighty":-30.723725,"marketCap":224108270},{"date":"2025-03-21","current":-27.23482,"twenty":-39.944402,"median":-34.681377,"eighty":-29.198812,"marketCap":196308580},{"date":"2025-03-28","current":-26.404128,"twenty":-39.576524,"median":-30.913597,"eighty":-27.946841,"marketCap":190320955},{"date":"2025-04-04","current":-9.026143,"twenty":-39.119644,"median":-30.068072,"eighty":-27.341623,"marketCap":185830236},{"date":"2025-04-11","current":-7.397773,"twenty":-38.751766,"median":-29.400552,"eighty":-17.252871,"marketCap":152305358},{"date":"2025-04-17","current":-7.977371,"twenty":-38.300819,"median":-28.45119,"eighty":-8.603741,"marketCap":164238114}],"updateTime":1745262234903}}}